Suppr超能文献

一种简化的体外疾病模拟培养系统可以确定药物对血管疾病的血管生成作用。

A simplified in vitro disease-mimicking culture system can determine the angiogenic effect of medicines on vascular diseases.

作者信息

Moon SongHo, Ito Yuzuru

机构信息

Institute of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki Japan.

Life Science Development Department, CHIYODA Corporation, Yokohama, Kanagawa Japan.

出版信息

Cytotechnology. 2025 Apr;77(2):75. doi: 10.1007/s10616-025-00736-4. Epub 2025 Mar 7.

Abstract

UNLABELLED

Many patients undergoing clinical regenerative treatments experience severe conditions arising from endothelial disruption. In chronic cardiac and perivascular diseases, deficiencies in vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), and heparin, which are essential for maintaining and activating endothelial cells, can lead to angiogenic dysregulation. Endothelial disruption caused by ischemic hypoxia and a deficiency in these factors is associated with many vascular diseases. However, their pathogenic processes remain unclear at the cellular level. Therefore, the present study aimed to develop a culture system that mimics the disease environment to test the effectiveness of drug candidates in restoring damaged blood vessels in chronic vascular diseases, including coronary artery disease and peripheral vascular disease. This study focused on VEGF, IGF, and heparin and developed a pseudo-disease culture system by pre-treating human umbilical vein endothelial cells (HUVECs) with a starvation medium (EGM-2™ medium lacking VEGF, IGF, and heparin) to examine the ability of HUVECs to form a traditional 2D vascular network. The results indicated that a deficiency in these proteins results in disruptions in tube morphogenesis. Moreover, the results suggested that dysregulation of the PI3K/AKT pathway plays a key role for in vascular disruption in HUVECs. The proposed pseudo-disease starvation system provides a simple way to visualize pathological disruptions to blood vessels and assess the efficacy of drugs for vascular regeneration.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s10616-025-00736-4.

摘要

未标注

许多接受临床再生治疗的患者会因内皮细胞破坏而出现严重病症。在慢性心脏和血管周围疾病中,血管内皮生长因子(VEGF)、胰岛素样生长因子(IGF)和肝素缺乏,而这些对于维持和激活内皮细胞至关重要,可导致血管生成失调。缺血缺氧以及这些因子缺乏所引起的内皮细胞破坏与许多血管疾病相关。然而,它们在细胞水平的致病过程仍不清楚。因此,本研究旨在开发一种模拟疾病环境的培养系统,以测试候选药物在修复包括冠状动脉疾病和外周血管疾病在内的慢性血管疾病中受损血管的有效性。本研究聚焦于VEGF、IGF和肝素,并通过用饥饿培养基(缺乏VEGF、IGF和肝素的EGM-2™培养基)预处理人脐静脉内皮细胞(HUVECs)来开发一种假疾病培养系统,以检测HUVECs形成传统二维血管网络的能力。结果表明,这些蛋白质的缺乏会导致管形态发生破坏。此外,结果表明PI3K/AKT信号通路失调在HUVECs血管破坏中起关键作用。所提出的假疾病饥饿系统提供了一种简单的方法来可视化血管的病理破坏并评估血管再生药物的疗效。

补充信息

在线版本包含可在10.1007/s10616-025-00736-4获取的补充材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/11889311/36d52bc37ece/10616_2025_736_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验